EA
MIRM icon

Ellsworth Advisors’s Mirum Pharmaceuticals MIRM Stock Holding History

Ellsworth Advisors’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.3M Buy
10,728
+99
+0.9% +$9.94K 0.21% 93
2026
Q1 		$982K Buy
+10,629
New +$1,000K 0.18% 101

Other funds holding MIRM

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
SAM
Secure Asset Management Troy, Michigan $714M AUM 27.91% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
JWS
Juncture Wealth Strategies Scottsdale, Arizona $384M AUM 27.62% 1-Year Est. Return
CIM
Contravisory Investment Management Norwell, Massachusetts $566M AUM 42.93% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return

Ellsworth Advisors's MIRM Position: Q2 2026 in Review

Ellsworth Advisors increased its Mirum Pharmaceuticals (MIRM) stake by 0.93% in Q2 2026, buying an estimated $9.94K and bringing the position to 10,728 shares worth $1.3M. The position accounts for 0.21% of the portfolio, ranked #93.

Ellsworth Advisors first reported a position in MIRM in Q1 2026 and has held it in 2 quarters since. 22 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Ellsworth Advisors held 10,728 shares of Mirum Pharmaceuticals worth $1.3M as of Q2 2026.
  • Ellsworth Advisors bought 99 Mirum Pharmaceuticals shares in Q2 2026, an estimated $9.94K.
  • Mirum Pharmaceuticals made up 0.21% of Ellsworth Advisors's portfolio in Q2 2026, its #93 holding.
  • Ellsworth Advisors first reported a position in Mirum Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 22 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Ellsworth Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.